231 related articles for article (PubMed ID: 33126341)
1. Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis.
Jia X; Guo R; Hu Z; Liu J; Liu J; Li B; Yang Q; He J
Medicine (Baltimore); 2020 Oct; 99(44):e22894. PubMed ID: 33126341
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis.
Zhao HN; Jiang M; Sun MJ; Dai C
Saudi J Gastroenterol; 2021; 27(4):191-200. PubMed ID: 34380865
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness of Tacrolimus and Infliximab in Hospitalized Patients With Ulcerative Colitis.
Takahashi T; Shiga H; Tarasawa K; Shimoyama Y; Naito T; Moroi R; Kuroha M; Kakuta Y; Fushimi K; Fujimori K; Kinouchi Y; Masamune A
Clin Transl Gastroenterol; 2024 Jan; 15(1):e00642. PubMed ID: 37753937
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Safety and Efficacy of Tacrolimus versus Infliximab for Active Ulcerative Colitis.
Takeuchi K; Shimoyama T; Yamamoto T
Dig Dis; 2018; 36(2):106-112. PubMed ID: 29050007
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids.
Narula N; Marshall JK; Colombel JF; Leontiadis GI; Williams JG; Muqtadir Z; Reinisch W
Am J Gastroenterol; 2016 Apr; 111(4):477-91. PubMed ID: 26856754
[TBL] [Abstract][Full Text] [Related]
6. A comparison of short-term therapeutic efficacy between infliximab and tacrolimus for moderate to severe ulcerative colitis.
Yamagami H; Nishida Y; Nagami Y; Hosomi S; Yukawa T; Otani K; Tanaka F; Taira K; Kamata N; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y
Rom J Intern Med; 2017 Sep; 55(3):151-157. PubMed ID: 28222041
[TBL] [Abstract][Full Text] [Related]
7. Short-Term and Long-Term Outcomes of Infliximab and Tacrolimus Treatment for Moderate to Severe Ulcerative Colitis: Retrospective Observational Study.
Otsuka T; Ooi M; Tobimatsu K; Wakahara C; Watanabe D; Adachi S; Yasutomi E; Yamairi H; Ku Y; Yoshida M; Hoshi N; Kodama Y
Kobe J Med Sci; 2018 Dec; 64(4):E140-E148. PubMed ID: 30728340
[TBL] [Abstract][Full Text] [Related]
8. Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis.
Liu YJ; Fan H; Zhen WW; Yu X; Chen JT; Wang CD
Medicine (Baltimore); 2018 Aug; 97(32):e11440. PubMed ID: 30095612
[TBL] [Abstract][Full Text] [Related]
9. Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients.
Duijvis NW; Ten Hove AS; Ponsioen CI; van den Brink GR; Buskens CJ; Bemelman WA; Te Velde AA; D'Haens GR; Löwenberg M
J Crohns Colitis; 2016 Jul; 10(7):821-7. PubMed ID: 26818660
[TBL] [Abstract][Full Text] [Related]
10. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
Nelson R; Liao C; Fichera A; Rubin DT; Pekow J
Inflamm Bowel Dis; 2014 Jan; 20(1):14-20. PubMed ID: 24297054
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Tacrolimus or Infliximab Therapy in Children and Young Adults With Acute Severe Colitis.
Zimmerman LA; Spaan J; Weinbren N; Manokaran K; Ajithkumar A; Bogursky A; Liu E; Lillehei C; Weil BR; Zalieckas JM; Bousvaros A; Rufo PA
J Pediatr Gastroenterol Nutr; 2023 Aug; 77(2):222-227. PubMed ID: 37477885
[TBL] [Abstract][Full Text] [Related]
12. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
Fernández-Salazar L; Muñoz F; Barrio J; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; Fernández N; Sánchez-Ocaña R; Joao D; Santos F
Scand J Gastroenterol; 2016; 51(2):186-95. PubMed ID: 26200929
[TBL] [Abstract][Full Text] [Related]
13. Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study.
Nasuno M; Miyakawa M; Tanaka H; Motoya S
Digestion; 2017; 95(1):67-71. PubMed ID: 28052276
[TBL] [Abstract][Full Text] [Related]
14. Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
Kopylov U; Papamichael K; Katsanos K; Waterman M; Bar-Gil Shitrit A; Boysen T; Portela F; Peixoto A; Szilagyi A; Silva M; Maconi G; Har-Noy O; Bossuyt P; Mantzaris G; Barreiro de Acosta M; Chaparro M; Christodoulou DK; Eliakim R; Rahier JF; Magro F; Drobne D; Ferrante M; Sonnenberg E; Siegmund B; Muls V; Thurm T; Yanai H; Dotan I; Raine T; Levin A; Israeli E; Ghalim F; Carbonnel F; Vermeire S; Ben-Horin S; Roblin X
Inflamm Bowel Dis; 2017 Sep; 23(9):1605-1613. PubMed ID: 28590343
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study.
Minami N; Yoshino T; Matsuura M; Koshikawa Y; Yamada S; Toyonaga T; Madian A; Honzawa Y; Nakase H
BMJ Open Gastroenterol; 2015; 2(1):e000021. PubMed ID: 26462273
[TBL] [Abstract][Full Text] [Related]
16. A Comparison of Short- and Long-Term Therapeutic Outcomes of Infliximab- versus Tacrolimus-Based Strategies for Steroid-Refractory Ulcerative Colitis.
Endo K; Onodera M; Shiga H; Kuroha M; Kimura T; Hiramoto K; Kakuta Y; Kinouchi Y; Shimosegawa T
Gastroenterol Res Pract; 2016; 2016():3162595. PubMed ID: 26904108
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the therapeutic efficacy and safety between tacrolimus and infliximab for moderate-to-severe ulcerative colitis: a single center experience.
Nuki Y; Esaki M; Asano K; Maehata Y; Umeno J; Moriyama T; Nakamura S; Matsumoto T; Kitazono T
Scand J Gastroenterol; 2016; 51(6):700-5. PubMed ID: 26818468
[TBL] [Abstract][Full Text] [Related]
18. Infliximab clinically treating ulcerative colitis: A systematic review and meta-analysis.
Guo C; Wu K; Liang X; Liang Y; Li R
Pharmacol Res; 2019 Oct; 148():104455. PubMed ID: 31562896
[TBL] [Abstract][Full Text] [Related]
19. Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis.
Wang X; Li Q; Sun S; Liang X; Li H; Huang J; Zhao T; Hu J; Liu J; Hu Z; Duan Y; He J
Medicine (Baltimore); 2022 Dec; 101(51):e31850. PubMed ID: 36595876
[TBL] [Abstract][Full Text] [Related]
20. Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis.
Moore H; Dolce P; Devas N; Baldassano R; Martinelli M
United European Gastroenterol J; 2020 May; 8(4):425-435. PubMed ID: 32213038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
